ATP2C1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.471800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.615400E-01
Normal-vs-Stage2
8.188200E-01
Normal-vs-Stage3
2.211400E-01
Normal-vs-Stage4
4.822800E-01
Stage1-vs-Stage2
3.682000E-02
Stage1-vs-Stage3
1.404240E-01
Stage1-vs-Stage4
1.757200E-01
Stage2-vs-Stage3
1.201770E-01
Stage2-vs-Stage4
1.027980E-01
Stage3-vs-Stage4
6.523900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.208000E-01
Normal-vs-AfricanAmerican
8.669200E-01
Normal-vs-Asian
6.720200E-01
Caucasian-vs-AfricanAmerican
8.560600E-01
Caucasian-vs-Asian
8.076400E-01
AfricanAmerican-vs-Asian
7.726800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.819200E-01
Normal-vs-Female
7.082000E-01
Male-vs-Female
8.811400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.147200E-01
Normal-vs-Age(41-60Yrs)
7.350600E-01
Normal-vs-Age(61-80Yrs)
4.981800E-01
Normal-vs-Age(81-100Yrs)
5.456000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.361800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.661800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.540800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.828600E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.219700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.316000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.692400E-01
Normal-vs-Daily Drinker
3.425600E-01
Normal-vs-Weekly Drinker
3.921800E-01
Normal-vs-Occasional Drinker
5.324600E-01
Normal-vs-Social Drinker
9.314600E-01
Non Drinker-vs-Daily Drinker
7.542400E-01
Non Drinker-vs-Weekly Drinker
8.817800E-01
Non Drinker-vs-Occasional Drinker
9.739000E-03
Non Drinker-vs-Social Drinker
1.321420E-01
Daily Drinker-vs-Weekly Drinker
9.084000E-01
Daily Drinker-vs-Occasional Drinker
4.738600E-03
Daily Drinker-vs-Social Drinker
1.101380E-01
Weekly Drinker-vs-Occasional Drinker
1.890270E-02
Weekly Drinker-vs-Social Drinker
1.782440E-01
Occasional Drinker-vs-Social Drinker
1.680210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.281580E-01
Normal-vs-Grade 2
1.615530E-02
Normal-vs-Grade 3
1.369500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.064100E-03
Grade 1-vs-Grade 3
6.414200E-04
Grade 1-vs-Grade 4
1.281580E-01
Grade 2-vs-Grade 3
1.567620E-01
Grade 2-vs-Grade 4
1.615530E-02
Grade 3-vs-Grade 4
1.369500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.161000E-01
Normal-vs-NonDiabetic
6.911200E-01
Diabetic-vs-NonDiabetic
6.444200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.264600E-01
Normal-vs-NoPancreatitis
6.893800E-01
Pancreatitis-vs-NoPancreatitis
7.494800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.404800E-01
Normal-vs-N1
8.562400E-01
N0-vs-N1
1.627410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.099000E-01
Normal-vs-TP53-NonMutant
4.062200E-01
TP53-Mutant-vs-TP53-NonMutant
1.76176999999722E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
